The UK-based surgical robot maker named Markus Bauman as its new chief legal & business affairs officer. CMR Surgical also officially added Michelle Paknad as SVP of global business development, as announced last month.
Bauman brings more than two decades of in-house legal experience to CMR Surgical, plus experience at global, renowned law firms. His track record includes working with innovative European companies and public and private financings and mergers and acquisitions.
Currently, Bauman serves as a member of the Atomico Expert Network, providing counsel and support to its portfolio of technology firms. He previously spent time as chief legal officer at Matillion, a software company specializing in data integration and transformation for cloud data warehouses. Bauman also had a stint as partner and head of European strategic relations at Goodwin.
Paknad joins CMR Surgical with responsibility for accelerating the company’s commercial efforts. She’s tasked with helping to bring Versius, the company’s surgical robot, to more hospitals around the world. Paknad brings more than 20 years of experience in the medical devices sector with particular experience in sales and marketing.
Her past includes significant experience within the space of soft tissue robotics as well. She spent time in senior sales and marketing roles at Intuitive and most recently served as VP of global robotics and digital health at Smith+Nephew. There, she ran the robotics franchise.
Commentary on the new appointments at CMR Surgical
Supratim Bose, CEO at CMR Surgical: “On behalf of the leadership team, I am delighted to welcome Markus and Michelle to CMR. Markus will be a key addition to the executive leadership team with his wealth of expertise in corporate law, strategic relations and financial operations. Michelle, with her extensive soft-tissue surgical robotics experience, will be instrumental in accelerating our commercial efforts and we look forward to utilising her skillset.”
Markus Bauman: “Given my experience of working with ambitious disruptive European businesses, I am looking forward to bringing my legal expertise to a company that is challenging the status quo in order to help bring more robotic-assisted surgery to patients around the world. Versius is a truly innovative technology, and I will work with the leadership team to ensure hospitals can realise the potential of this technology.”
Michelle Paknad: “I am excited to join a Company that is looking to disrupt the surgical robotics market. Soft-tissue surgical robotics is such a fast growing and changing market, and I look forward to bringing my extensive experience in this industry to partner with surgeons and hospitals so that more patients can get the benefits of robotic-assisted surgery with Versius.”
